Alzheimer-Demenz: Behandlung
Über den Vortrag
Der Vortrag „Alzheimer-Demenz: Behandlung“ von Roy Strowd, MD ist Bestandteil des Kurses „Alzheimer-Demenz“.
Quiz zum Vortrag
Which class of pharmacologic agents is most commonly used to treat Alzheimer dementia?
- Cholinesterase inhibitors
- Anticholinergics
- Norepinephrine reuptake inhibitors
- Dopamine antagonists
- MAO-inhibitors
Which of the following drugs are cholinesterase inhibitors that are used in the treatment of Alzheimer dementia?
- All of the answer options are valid.
- Galantamine
- Donepezil
- Rivastigmine
Memantine is a pharmacologic agent used in the treatment of moderate-to-severe dementia. What is its mechanism of action?
- NMDA antagonist
- Cholinesterase inhibitor
- Anticholinergic
- SSRI
- Antipsychotic
Often, in older patients, comorbid depression can masquerade as worsening dementia and must be treated. Which class of agents is often used in patients with dementia and comorbid depression to treat the depression?
- SSRIs
- SNRIs
- Antipsychotics
- Anticholinergics
- Cholinesterase inhibitors
Diese Kurse könnten Sie interessieren
Dozent des Vortrages Alzheimer-Demenz: Behandlung
Roy Strowd, MD
Dr. Roy Strowd is the Assistant Dean of Undergraduate Medical Education at the Wake Forest Baptist Medical Center, in North Carolina, USA.
He obtained his MD from Wake Forest School of Medicine in 2009, and his MEd from Johns Hopkins University in 2021. Currently, he co-directs the Neurofibromatosis and Tuberous Sclerosis Clinics at Wake Forest Baptist Medical Center, and is a researcher for the Adult Brain Tumor Consortium (ABTC) and Alliance for Clinical Trials in Neuro-Oncology.
Due to his achievements, he earned the M. Brownell Anderson Award from the Association of American Medical Colleges.
Within Lecturio, Dr. Strowd teaches courses on Clinical Neurology.
Kundenrezensionen
5,0 von 5 Sternen
| 5 Sterne |
|
5 |
| 4 Sterne |
|
0 |
| 3 Sterne |
|
0 |
| 2 Sterne |
|
0 |
| 1 Stern |
|
0 |
